Irhythm Technologies (NASDAQ:IRTC) is set to release its earnings data after the market closes on Wednesday, February 14th. Analysts expect Irhythm Technologies to post earnings of ($0.35) per share for the quarter.
Irhythm Technologies (IRTC) opened at $57.92 on Wednesday. The company has a quick ratio of 7.57, a current ratio of 7.65 and a debt-to-equity ratio of 0.38. The company has a market cap of $1,340.74, a price-to-earnings ratio of -48.67 and a beta of 1.56. Irhythm Technologies has a one year low of $32.10 and a one year high of $66.20.
In other Irhythm Technologies news, CFO Matthew C. Garrett sold 1,193 shares of the business’s stock in a transaction on Monday, December 4th. The shares were sold at an average price of $55.00, for a total transaction of $65,615.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Matthew C. Garrett sold 42,910 shares of the business’s stock in a transaction on Friday, January 5th. The shares were sold at an average price of $59.17, for a total transaction of $2,538,984.70. Following the transaction, the chief financial officer now directly owns 36,085 shares in the company, valued at $2,135,149.45. The disclosure for this sale can be found here. Over the last three months, insiders have sold 476,533 shares of company stock worth $25,222,506. Insiders own 23.30% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Irhythm Technologies (IRTC) Set to Announce Earnings on Wednesday” was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece on another domain, it was illegally stolen and republished in violation of US and international copyright legislation. The original version of this piece can be accessed at https://www.americanbankingnews.com/2018/02/07/irhythm-technologies-irtc-set-to-announce-earnings-on-wednesday.html.
About Irhythm Technologies
iRhythm Technologies, Inc is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report.
Receive News & Ratings for Irhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Irhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.